Skip to main content
. 2022 Jun 9;17(6):e0268780. doi: 10.1371/journal.pone.0268780

Fig 2. Anti-S quantity subgroup analysis.

Fig 2

All included patients were divided into subgroups according to baseline total IgG levels at start of immunoglobulin replacement therapy. Kruskal-Wallis test was calculated for the comparison of the IgG subgroups and healthy control: p = 0.002. Anti-SARS-CoV-2 spike protein antibodies (anti-S).